| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 134, 231-235, Copyright © 1989 by American Society for Investigative Pathology
REGULAR ARTICLES |
SA Vinores, C Gadegbeku, PA Campochiaro and WR Green
Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville.
Localization of the site of blood-retinal barrier breakdown in diabetes has been controversial. It has been particularly difficult to make assessments in clinical material where the use of tracer materials may not be practical. In this study, immunohistochemical staining for albumin was performed on paraffin-embedded eyes from patients with no known ocular disease and those with various stages of diabetic retinopathy. No extravascular albumin was detected in the retina or retinal pigment epithelium (RPE) of normal nondiabetics or diabetics with no ocular findings, but it was detected in 12.5% of mildly affected diabetics, 20% of background diabetic retinopathy cases, and 89% of proliferative diabetic retinopathy cases. The inner retinal vasculature appeared to be the primary site of leakage in diabetics because all cases demonstrating extravascular albumin-positivity expressed it in the inner retina. It usually permeated the vessel walls and spread along the inner surface of the retina. Some of these cases also contained albumin in the outer retina and RPE, suggesting that additional leakage also may occur through the RPE. A case of cytomegalovirus (CMV) retinitis showed albumin staining predominantly in the inner retina, whereas a rhegmatogenous retinal detachment showed only outer retina staining. These data suggest immunohistochemical staining for albumin may be a useful technique for localizing blood- retinal barrier breakdown.
This article has been cited by other articles:
![]() |
J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5152 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muranaka, Y. Yanagi, Y. Tamaki, T. Usui, N. Kubota, A. Iriyama, Y. Terauchi, T. Kadowaki, and M. Araie Effects of Peroxisome Proliferator-Activated Receptor {gamma} and Its Ligand on Blood-Retinal Barrier in a Streptozotocin-Induced Diabetic Model. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4547 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X. Zhang, J.-x. Ma, J. Sima, Y. Chen, M. S. Hu, A. Ottlecz, and G. N. Lambrou Genetic Difference in Susceptibility to the Blood-Retina Barrier Breakdown in Diabetes and Oxygen-Induced Retinopathy Am. J. Pathol., January 1, 2005; 166(1): 313 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Barber and D. A. Antonetti Mapping the Blood Vessels with Paracellular Permeability in the Retinas of Diabetic Rats Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5410 - 5416. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nitta, M. Hata, S. Gotoh, Y. Seo, H. Sasaki, N. Hashimoto, M. Furuse, and S. Tsukita Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice J. Cell Biol., May 12, 2003; 161(3): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Derevjanik, S. A. Vinores, W.-H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2462 - 2467. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Qaum, Q. Xu, A. M. Joussen, M. W. Clemens, W. Qin, K. Miyamoto, H. Hassessian, S. J. Wiegand, J. Rudge, G. D. Yancopoulos, et al. VEGF-initiated Blood-Retinal Barrier Breakdown in Early Diabetes Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2408 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Barber, D. A. Antonetti, and T. W. Gardner Altered Expression of Retinal Occludin and Glial Fibrillary Acidic Protein in Experimental Diabetes Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3561 - 3568. [Abstract] [Full Text] |
||||
![]() |
D. N. Henry, R. N. Frank, S. R. Hootman, S. E. Rood, C. W. Heilig, and J. V. Busik Glucose-Specific Regulation of Aldose Reductase in Human Retinal Pigment Epithelial Cells In Vitro Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1554 - 1560. [Abstract] [Full Text] |
||||
![]() |
D. KENT, S. A VINORES, and P. A CAMPOCHIARO Macular oedema: the role of soluble mediators Br. J. Ophthalmol., May 1, 2000; 84(5): 542 - 545. [Full Text] |
||||
![]() |
K. Miyamoto, S. Khosrof, S.-E. Bursell, R. Rohan, T. Murata, A. C. Clermont, L. P. Aiello, Y. Ogura, and A. P. Adamis Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition PNAS, September 14, 1999; 96(19): 10836 - 10841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |